A National Survey Investigating UK Prescribers' Opinions on Chemotherapy Dosing and 'Dose-Banding'

There was general support for dose-banding, but concerns about the lack of an evidence base could be a barrier to the wider introduction of the system. Consequently, more clinical studies are required to justify the safety and efficacy of dose-banding, and also to evaluate whether dose-banding is acceptable within clinical trials.